Generate a tailored SOP for Dr. Shili Xu. Improve your application with a focused, well-structured draft.
Shili Xu is an Assistant Professor in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles. He serves as the Director of Preclinical Imaging at the Crump Institute for Molecular Imaging and is a member of the Jonsson Comprehensive Cancer Center. His research focuses on the development of advanced molecular imaging technologies, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), computed tomography (CT), and magnetic resonance imaging (MRI). He is particularly interested in non-invasive assessment techniques for cancer, immune responses, and various biological processes associated with neurology and cardiology. Xu's investigations involve the creation and application of PET probes that allow for the preclinical imaging of cellular metabolism and tracking of cell activation in response to pharmacological interventions. His work also aims to combine PET and SPECT imaging to develop theranostic radiopharmaceuticals for cancer management. Key areas of his research include the development of novel imaging probes and the application of these technologies to enhance cancer therapy.
Department of Economics admits primarily for the PhD program.